XPeng (09868.HK), KEYMED BIO-B (02162.HK) IPOs Over-subscribed by 1.4x, 69x
XPeng (09868.HK), KEYMED BIO-B (02162.HK) IPOs Over-subscribed by 1.4x, 69x
XPeng(09868.HK)、KeyMed BIO-B(02162.HK)IPO超额认购1.4倍、69倍
Brokers have so far granted $1.83 billion margin to the IPO of XPeng (09868.HK)(XPEV.US) on the first day of public offering as at around 6 pm. The IPO was thus over-subscribed by almost 1.4 times based on the fundraising amount of $765 million from the public offering.
KEYMED BIO-B (02162.HK), on the first day of public offering as well, recorded $21.72 billion subscription. The IPO was thus over-subscribed by almost 69 times based on the fundraising amount of $310 million from the public offering.
截至下午6点左右，券商迄今已向XPeng(09868.HK)(XPEV.US)首日公开发行的IPO授予18.3亿美元保证金。因此，根据公开募股7.65亿美元的筹资金额，IPO获得了近1.4倍的超额认购。KeyMed BIO-B(02162.HK)在公开募股的第一天也获得了217.2亿美元的认购。因此，根据公开募集的3.1亿美元资金，此次IPO获得了近69倍的超额认购。